Cytek Biosciences Inc (CTKB) — Free Cash Flow Generation Index
Cytek Biosciences Inc (CTKB) has a Free Cash Flow Generation Index of -13.60x as of June 2025. Free cash flow of $-1.47 Million represents -14% of operating cash flow ($108.00K). Explore reinvestment intensity of Cytek Biosciences Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Cytek Biosciences Inc Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for Cytek Biosciences Inc across 4 annual periods. For the full cash flow conversion analysis, see CTKB cash flow metrics.
Annual Free Cash Flow Generation for Cytek Biosciences Inc (2020–2024)
Year-by-year Free Cash Flow Generation Index for Cytek Biosciences Inc. Check cash flow reinvestment rate of Cytek Biosciences Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.86x | $21.85 Million | $25.38 Million | $3.52 Million | ▲ +901.7% |
| 2023 | 0.09x | $454.00K | $5.28 Million | $4.83 Million | ▲ +49.6% |
| 2021 | 0.06x | $266.00K | $4.63 Million | $4.36 Million | ▼ -93.6% |
| 2020 | 0.90x | $13.61 Million | $15.16 Million | $1.55 Million | — |